MedTrace Logo

Effects of Peanuts on Immunity and Cardiometabolic Risk Factors

NCT06159556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-10-02

No results posted yet for this study

Summary

The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors.

Conditions

  • Immune Response
  • Cardiometabolic Risk Factors

Interventions

OTHER

Peanut intake

Participants will consume 2 ounces of peanuts/peanut butter for 12 weeks

Sponsors & Collaborators

  • California Walnut Commission

    collaborator OTHER

  • Loma Linda University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-09-26
Completion
2024-09-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06159556 on ClinicalTrials.gov